Literature DB >> 15078679

Current concepts in the pathogenesis of age-related macular degeneration.

Marco A Zarbin1.   

Abstract

OBJECTIVE: To review and synthesize information concerning the pathogenesis of age-related macular degeneration (AMD).
METHODS: Review of the English-language literature.
RESULTS: Five concepts relevant to the cell biology of AMD are as follows: (1) AMD involves aging changes plus additional pathological changes (ie, AMD is not just an aging change); (2) in aging and AMD, oxidative stress causes retinal pigment epithelial (RPE) and, possibly, choriocapillaris injury; (3) in AMD (and perhaps in aging), RPE and, possibly, choriocapillaris injury results in a chronic inflammatory response within the Bruch membrane and the choroid; (4) in AMD, RPE and, possibly, choriocapillaris injury and inflammation lead to formation of an abnormal extracellular matrix (ECM), which causes altered diffusion of nutrients to the retina and RPE, possibly precipitating further RPE and retinal damage; and (5) the abnormal ECM results in altered RPE-choriocapillaris behavior leading ultimately to atrophy of the retina, RPE, and choriocapillaris and/or choroidal new vessel growth. In this sequence of events, both the environment and multiple genes can alter a patient's susceptibility to AMD. Implicit in this characterization of AMD pathogenesis is the concept that there is linear progression from one stage of the disease to the next. This assumption may be incorrect, and different biochemical pathways leading to geographic atrophy and/or choroidal new vessels may operate simultaneously.
CONCLUSIONS: Better knowledge of AMD cell biology will lead to better treatments for AMD at all stages of the disease. Many unanswered questions regarding AMD pathogenesis remain. Multiple animal models and in vitro models of specific aspects of AMD are needed to make rapid progress in developing effective therapies for different stages of the disease.

Entities:  

Mesh:

Year:  2004        PMID: 15078679     DOI: 10.1001/archopht.122.4.598

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  345 in total

1.  Bone marrow-derived cells home to and regenerate retinal pigment epithelium after injury.

Authors:  Jeffrey R Harris; Gary A J Brown; Marda Jorgensen; Shalesh Kaushal; E Ann Ellis; Maria B Grant; Edward W Scott
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

Review 2.  Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degeneration.

Authors:  Fu Shang; Allen Taylor
Journal:  Mol Aspects Med       Date:  2012-04-10

3.  Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells.

Authors:  Qingning Bian; Shasha Gao; Jilin Zhou; Jian Qin; Allen Taylor; Elizabeth J Johnson; Guangwen Tang; Janet R Sparrow; Dennis Gierhart; Fu Shang
Journal:  Free Radic Biol Med       Date:  2012-06-23       Impact factor: 7.376

Review 4.  Stemming vision loss with stem cells.

Authors:  Valentina Marchetti; Tim U Krohne; David F Friedlander; Martin Friedlander
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

5.  An eye for discovery.

Authors:  Andreas Stahl; Lois E H Smith
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

6.  Analysis of single nucleotide polymorphisms in the NOS2A gene and interaction with smoking in age-related macular degeneration.

Authors:  Juan A Ayala-Haedo; Paul J Gallins; Patrice L Whitehead; Stephen G Schwartz; Jaclyn L Kovach; Eric A Postel; Anita Agarwal; Gaofeng Wang; Jonathan L Haines; Margaret A Pericak-Vance; William K Scott
Journal:  Ann Hum Genet       Date:  2010-03-31       Impact factor: 1.670

Review 7.  The electroretinogram: a useful tool for evaluating age-related macular disease?

Authors:  Emma J Berrow; Hannah E Bartlett; Frank Eperjesi; Jonathan M Gibson
Journal:  Doc Ophthalmol       Date:  2010-03-16       Impact factor: 2.379

8.  Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.

Authors:  Wai T Wong; Waynekid Kam; Denise Cunningham; Molly Harrington; Keri Hammel; Catherine B Meyerle; Catherine Cukras; Emily Y Chew; Srinivas R Sadda; Frederick L Ferris
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-23       Impact factor: 4.799

9.  Retinal pigment epithelium resurfacing of aged submacular human Bruch's membrane.

Authors:  Vamsi K Gullapalli; Ilene K Sugino; Yancy Van Patten; Sumit Shah; Marco A Zarbin
Journal:  Trans Am Ophthalmol Soc       Date:  2004

10.  Inhibition of development of laser-induced choroidal neovascularization with suppression of infiltration of macrophages in Smad3-null mice.

Authors:  Hiroki Iwanishi; Norihito Fujita; Katsuo Tomoyose; Yuka Okada; Osamu Yamanaka; Kathleen C Flanders; Shizuya Saika
Journal:  Lab Invest       Date:  2016-03-07       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.